Jesse W. Hall

Dr. Hall is currently the Chief Medical Officer of AltruBio, Inc. Prior to joining AltruBio, he was Executive Vice President and Chief Medical Officer at Sublimity Therapeutics, a clinical-stage biotechnology company from 2018 to 2021. From 2013 to 2018, Dr. Hall served as an Executive Medical Director of Ardea Biosciences Inc., a biotechnology company. From 2009 to 2013, Dr. Hall held the position of Medical Director for Amgen Inc., a biopharmaceutical company. From 2004 to 2009, Dr. Hall held multiple positions of increasing responsibilities at Abbott Laboratories, a multinational medical devices and health care company.

Dr. Hall completed his B.A. in Ocean Studies and Economics from the University of San Diego and his M.D. from the College of Medicine at the University of Oklahoma.